Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Laboratorios Roemmers S.A.I.C.F.
- Target Recruit Count
- 135
- Registration Number
- NCT04463264
- Locations
- 🇦🇷
Hospital Universitario Austral, Presidente Derqui, Buenos Aires, Argentina, Argentina
News
No news found